Cowen & Co.
TD Cowen Initiates Coverage of MDxHealth With Outperform Rating
Analyst Dan Brennan wrote in a note to investors that the company's position in an under-penetrated market bodes well for future revenue growth.
TD Cowen Upgrades Shares of Pacific Biosciences to Outperform
A survey revealed that labs with multiple PacBio Sequel instruments plan to buy an average of three Revio sequencers each, TD Cowen Analyst Dan Brennan said.
Pacific Biosciences to Raise $175M in Public Stock Offering
The company is selling 17.5 million shares of its common stock at a price of $10 per share in the offering, which is expected to close Jan. 27.
Cowen Initiates Coverage of 23andMe With Outperform Rating
The investment bank pointed to 23andMe's unique and hard-to-replicate population-scale genetic database as a key growth driver.
Cowen Initiates Coverage of Ginkgo Bioworks With Outperform Rating
Ginkgo Bioworks went public in September through a SPAC merger, raising $1.63 billion in proceeds. Cowen joins BTIG in covering shares of the firm.
May 24, 2021
Singular Genomics Ups IPO Target to $187M
Mar 15, 2021
Roche to Acquire GenMark Diagnostics for $1.8B
Dec 2, 2020
Twist Bioscience Proposes $250M Public Offering
Sep 11, 2020
10x Genomics Prices Upsized $440M Public Offering
Jul 17, 2020
Berkeley Lights Prices Upsized $178.2M IPO
Jun 4, 2020